T Cell Factor 4 Is Involved in Papillary Thyroid Carcinoma via Regulating Long Non-Coding RNA HCP5
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 19
Abstract
The annual incidence of papillary thyroid carcinoma has increased dramatically. T cell factor 4 (TCF4) is an important component of Wnt signaling pathway.However, the role of TCF4 in PTC remains unknown. In this study, TCF4 was observed to overexpress in PTC patients and cells by qRT-PCR assay. The colony formation assay, Edu staining and transwell assay indicated thatoverexpression of TCF4 promoted cell proliferation and invasion of TCP-1 cells, whereas knockdown of TCF4 inhibited cell proliferation and invasion of IHH-4 cells. To investigate the mechanism of TCF4 in PTC cells, the luciferase assay demonstrated that TCF4 could modulate HCP5 expression. Besides, GLuc-ON promoter reporter assayproved that TCF4 could bind to HCP5 promoter. Further, knockdown of HCP5 could significantly up-regulated miR-15a, miR-216a-5p, miR-22-3p, miR-139-5p, miR-203, miR-27a-3p and miR-320, and down-regulated miR-186-5p in IHH-4 cells, which might be potential downstream of TFC4/HCP5 axis. In conclusion, up-regulation TCF4 can promote HCP5 expression via binding to HCP5 promoter. It may be the first time to prove that TCF4 regulates HCP5 in PTC, which provides a novel sight for treatment of PTC.Keywords
Funding Information
- Key Project of Science and Technology Planning of Health in Hangzhou (2018ZD02)
This publication has 36 references indexed in Scilit:
- Knockdown of Human TCF4 Affects Multiple Signaling Pathways Involved in Cell Survival, Epithelial to Mesenchymal Transition and Neuronal DifferentiationPLOS ONE, 2013
- Wnt/β-Catenin Signaling Pathway Is a Direct Enhancer of Thyroid Transcription Factor-1 in Human Papillary Thyroid Carcinoma CellsPLOS ONE, 2011
- Thyroid Cancer: Burden of Illness and Management of DiseaseJournal of Cancer, 2011
- A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other CancersCurrent Oncology Reports, 2010
- Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005Cancer, 2009
- Wnt/β-Catenin Signaling: Components, Mechanisms, and DiseasesDevelopmental Cell, 2009
- β-Catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinomaCancer Letters, 2008
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402Cell Research, 2004
- Prognosis After Lymph Node Recurrence in Papillary Thyroid Carcinoma Depends on AgeThyroid®, 2001